Immunotherapy for Treating Kidney Diseases

Immunotherapy Centre was set up in early 2009 in the hospital, and two types of Immunotherapy have already been applied to treating kidney diseases. Immunotherapy (SCT) is based on the adoption of Micro-Chinese Medicine Osmotherapy (MCMO). MCMO is the basis on treating kidney diseases, and SCT is like ‘adding brilliance to one’s present splendor’. Umbilical Mesangial Immunotherapy and Umbilical Cord Blood Immunotherapy are applied to treating kidney diseases in the hospital. These two types of Immunotherapy are Adult Immunotherapy and cultivated in the hospital Immunotherapy centre.

1. Promote the self-repairing of damaged kidney cells.

The adoption of Micro-Chinese Medicine Osmotherapy effectively protects kidney function from further decline, and creates a favorable environment for damaged cells’ self-repairing. However, these recovering cells are fragile, and the function recovery also takes a long time.

Immunotherapy works in two aspects, A) help with repairing damages in other body parts (like damages in blood vessels), which consolidates the favorable environment for damaged cells self-repairing. B). help with repairing damaged kidney cells directly, and provide them with necessary materials.

2. Regenerate new functional kidney intrinsic cells.

Based on damaged cells self-repairing, the overall kidney function improvement is limited. Umbilical Mesangial Immunotherapy mainly differentiate into substantial organ cells like Liver and Kidneys. Under the help of MCMO, Umbilical Mesangial Immunotherapy concentrate on kidneys and regenerate new functional kidney intrinsic cells. In addition, due to kidney function decline, patients commonly experience Anemia of varying degree, or blood circulation problem. Umbilical Cord Blood Immunotherapy mainly differentiate into cells related to blood.

The Therapeutical process of Immunotherapy

1. These two types of Immunotherapy are collected from Umbilical Cord after the birth of baby, and then cultivated in the hospital’s Immunotherapy centre. Commonly, the cultivation process takes 10 days, and when Immunotherapy grow to maturity, they are transfused into body through intravenous injection.

2. As mentioned above, Immunotherapy are transfused into body through intravenous injection (like intravenous drip), and no operation is needed.

3. Nearly ten to fifteen days after patient’s hospitalization, Umbilical Cord Immunotherapy will be done, and seven to ten days later Umbilical Mesangial Immunotherapy will be conducted. If needed, another Umbilical Cord Blood Immunotherapy or Umbilical Mesangial Immunotherapy will be conducted before the patient’s leaving of the hospital.


Commonly, it takes three to six months before Immunotherapy’ actual taking effects in restoring overall kidney function. During this process, Micro-Chinese Medicine Osmotherapy is needed to protect remained kidney function, as well as maintaining a favorable internal environment for the growth of Immunotherapy within body.